Azahari Kasbollah
Overview
Explore the profile of Azahari Kasbollah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
74
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alregib A, Tan H, Wong Y, Kasbollah A, Wong E, Abdullah B, et al.
J Labelled Comp Radiopharm
. 2023 Jun;
66(10):308-320.
PMID: 37287213
Transarterial chemoembolization (TACE) and transarterial radioembolization (TARE) are promising treatments for unresectable liver tumours. Some recent studies suggested that combining TACE and TARE in one treatment course might improve treatment...
2.
Wong Y, Kasbollah A, Abdullah B, Yeong C
Pharmaceutics
. 2023 Mar;
15(3).
PMID: 36986738
Radioembolization shows great potential as a treatment for intermediate- and advanced-stage liver cancer. However, the choices of radioembolic agents are currently limited, and hence the treatment is relatively costly compared...
3.
Tan H, Wong Y, Kasbollah A, Md Shah M, Yahya N, Abdullah B, et al.
Pharmaceutics
. 2023 Feb;
15(2).
PMID: 36839858
Neutron-activated samarium-153-oxide-loaded polystyrene ([Sm]SmO-PS) microspheres has been developed in previous study as a potential theranostic agent for hepatic radioembolization. In this study, the therapeutic efficacy and diagnostic imaging capabilities of...
4.
Tan H, Wong Y, Kasbollah A, Md Shah M, Perkins A, Yeong C
Nucl Med Commun
. 2023 Feb;
44(4):227-243.
PMID: 36808108
Personalised cancer treatment is of growing importance and can be achieved via targeted radionuclide therapy. Radionuclides with theranostic properties are proving to be clinically effective and are widely used because...
5.
de Silva L, Fu J, Htar T, Wan Kamal W, Kasbollah A, Muniyandy S, et al.
Front Pharmacol
. 2022 Jan;
12:778396.
PMID: 35069200
The purpose of this work was to study the biodistribution of niosomes in tumor-implanted BALB/c mice using gamma scintigraphy. Niosomes were first formulated and characterized, then radiolabeled with Technetium-99 m...
6.
Tan H, Wong Y, Kasbollah A, Md Shah M, Abdullah B, Perkins A, et al.
Nucl Med Commun
. 2022 Jan;
43(4):410-422.
PMID: 35045548
Purpose: Hepatic radioembolization is an effective minimally invasive treatment for primary and metastatic liver cancers. Yttrium-90 [90Y]-labelled resin or glass beads are typically used as the radioembolic agent for this...
7.
Tan H, Yeong C, Wong Y, McKenzie M, Kasbollah A, Md Shah M, et al.
Nucl Med Biol
. 2020 Oct;
90-91:55-68.
PMID: 33039974
Theranostics in nuclear medicine refers to personalized patient management that involves targeted therapy and diagnostic imaging using a single or combination of radionuclide (s). The radionuclides emit both alpha (α)...
8.
Wong Y, Tan H, Kasbollah A, Abdullah B, Acharya R, Yeong C
World J Exp Med
. 2020 Apr;
10(2):10-25.
PMID: 32266125
Background: Liver cancer is the 6 most common cancer in the world and the 4 most common death from cancer worldwide. Hepatic radioembolization is a minimally invasive treatment involving intraarterial...
9.
Wong Y, Tan H, Kasbollah A, Abdullah B, Yeong C
Pharmaceutics
. 2019 Nov;
11(11).
PMID: 31718079
Introduction: Transarterial radioembolization (TARE) has been proven as an effective treatment for unresectable liver tumor. In this study, neutron activated, Sm-labeled microspheres were developed as an alternative to Y-labeled microspheres...
10.
de Silva L, Fu J, Htar T, Muniyandy S, Kasbollah A, Wan Kamal W, et al.
Int J Nanomedicine
. 2019 Mar;
14:1101-1117.
PMID: 30863048
Background And Purpose: Niosomes are nonionic surfactant-based vesicles that exhibit certain unique features which make them favorable nanocarriers for sustained drug delivery in cancer therapy. Biodistribution studies are critical in...